DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
ACETIC ACID C-11
2
Small molecule
Investigational
Unknown
Unknown
Fatty Liver; Carcinoma, Hepatocellular; Cognitive Dysfunction
Unknown
ACETIC ACID C-11
×
Maximum Phase:
2
First Approval:
None
UNII:
2A9OM7IPNW
Molecule Type:
Small molecule
Molecular Formula:
C2H4O2
Molecular Weight:
59.05
AlogP:
0.09
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
F901318
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
F901318
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VIPIVOTIDE TETRAXETAN GALLIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VIPIVOTIDE TETRAXETAN GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C49H68GaN9O16
Molecular Weight:
1108.85
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SAF312
2
Small molecule
Investigational
Unknown
Unknown
Eye Pain; Pain; Urinary Bladder, Neurogenic
Vanilloid receptor inhibitor
SAF312
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUINACRINE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Carcinoma, Renal Cell; Creutzfeldt-Jakob Syndrome; Prostatic Neoplasms, Castration-Resistant; Amebiasis
Unknown
QUINACRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
H0C805XYDE
Molecule Type:
Small molecule
Molecular Formula:
C23H30ClN3O
Molecular Weight:
399.97
AlogP:
5.97
PSA:
37.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
BMS-863233
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Cell division cycle 7-related protein kinase inhibitor
BMS-863233
×
Maximum Phase:
2
First Approval:
None
UNII:
8QK62S7492
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O2
Molecular Weight:
289.72
AlogP:
2.75
PSA:
70.92
HBD:
2.0
HBA:
#RotB:
1.0
Source:
ATX08-001
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Neuralgia, Postherpetic
Peroxisome proliferator-activated receptor gamma modulator
ATX08-001
×
Maximum Phase:
2
First Approval:
None
UNII:
V5Q32BZX79
Molecule Type:
Small molecule
Molecular Formula:
C21H23Cl2N3O3S
Molecular Weight:
468.41
AlogP:
4.95
PSA:
81.06
HBD:
1.0
HBA:
#RotB:
8.0
Source:
QUERCETIN-3'-O-PHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Glucose Intolerance
Unknown
QUERCETIN-3'-O-PHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
E2I4458LJN
Molecule Type:
Small molecule
Molecular Formula:
C15H11O10P
Molecular Weight:
382.22
AlogP:
1.75
PSA:
177.89
HBD:
6.0
HBA:
#RotB:
3.0
Source:
ANABASEINE
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ANABASEINE
×
Maximum Phase:
2
First Approval:
None
UNII:
DYE103K23I
Molecule Type:
Small molecule
Molecular Formula:
C10H12N2
Molecular Weight:
160.22
AlogP:
2.05
PSA:
25.25
HBD:
0.0
HBA:
#RotB:
1.0
Source:
NEOANDROGRAPHOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Chronic Progressive; Colorectal Neoplasms
Unknown
NEOANDROGRAPHOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
XBY0Z806J2
Molecule Type:
Small molecule
Molecular Formula:
C26H40O8
Molecular Weight:
480.6
AlogP:
1.85
PSA:
125.68
HBD:
4.0
HBA:
#RotB:
7.0
Source:
SAMIDORPHAN
2
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders; Alcoholism; Feeding and Eating Disorders; Schizophrenia
Mu opioid receptor antagonist
SAMIDORPHAN
×
Maximum Phase:
2
First Approval:
None
UNII:
7W2581Z5L8
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O4
Molecular Weight:
370.45
AlogP:
1.25
PSA:
103.86
HBD:
3.0
HBA:
#RotB:
3.0
Source:
DAPORINAD
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, T-Cell, Cutaneous; Melanoma
Nicotinamide phosphoribosyltransferase inhibitor
DAPORINAD
×
Maximum Phase:
2
First Approval:
None
UNII:
V71TF6V9M7
Molecule Type:
Small molecule
Molecular Formula:
C24H29N3O2
Molecular Weight:
391.52
AlogP:
3.93
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PREDNYLIDENE
2
Small molecule
Investigational
Unknown
Unknown
Granulomatosis with Polyangiitis; Microscopic Polyangiitis
Unknown
PREDNYLIDENE
×
Maximum Phase:
2
First Approval:
None
UNII:
IF8PQP966U
Molecule Type:
Small molecule
Molecular Formula:
C22H28O5
Molecular Weight:
372.46
AlogP:
1.72
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
2.0
Source:
TAS-106
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Head and Neck Neoplasms
DNA-directed RNA polymerase III subunit RPC1 inhibitor
TAS-106
×
Maximum Phase:
2
First Approval:
None
UNII:
Y3O05I09ZK
Molecule Type:
Small molecule
Molecular Formula:
C11H13N3O5
Molecular Weight:
267.24
AlogP:
-2.56
PSA:
130.83
HBD:
4.0
HBA:
#RotB:
2.0
Source:
TOLIMIDONE
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Tyrosine-protein kinase Lyn positive allosteric modulator
TOLIMIDONE
×
Maximum Phase:
2
First Approval:
None
UNII:
MU3JD8E9IS
Molecule Type:
Small molecule
Molecular Formula:
C11H10N2O2
Molecular Weight:
202.21
AlogP:
2.28
PSA:
55.24
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TAK-715
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
MAP kinase p38 alpha inhibitor
TAK-715
×
Maximum Phase:
2
First Approval:
None
UNII:
WE92U03C5Z
Molecule Type:
Small molecule
Molecular Formula:
C24H21N3OS
Molecular Weight:
399.52
AlogP:
6.0
PSA:
54.88
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AMITHIOZONE
2
Small molecule
Investigational
Unknown
Unknown
Mycobacterium avium-intracellulare Infection; Tuberculosis
Unknown
AMITHIOZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
MMG78X7SSR
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4OS
Molecular Weight:
236.3
AlogP:
0.81
PSA:
79.51
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TOVINONTRINE
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell; beta-Thalassemia; Heart Failure
Phosphodiesterase 9A inhibitor
TOVINONTRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W248Y1AKOR
Molecule Type:
Small molecule
Molecular Formula:
C21H26N6O2
Molecular Weight:
394.48
AlogP:
1.94
PSA:
88.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BERSACAPAVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis; Hepatitis B; Liver Diseases; Renal Insufficiency; Hepatitis B, Chronic
Core antigen modulator
BERSACAPAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
2456KW2166
Molecule Type:
Small molecule
Molecular Formula:
C16H14F4N4O3S
Molecular Weight:
418.37
AlogP:
2.52
PSA:
103.99
HBD:
2.0
HBA:
#RotB:
5.0
Source:
GOVORESTAT
2
Small molecule
Investigational
Unknown
Unknown
Peripheral Nervous System Diseases; Galactosemias
Unknown
GOVORESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
6JLQ8K35KK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F3N3O3S2
Molecular Weight:
425.41
AlogP:
3.76
PSA:
85.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BRILACIDIN
2
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Membrane disrupting agent
BRILACIDIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I1679X069H
Molecule Type:
Small molecule
Molecular Formula:
C40H50F6N14O6
Molecular Weight:
936.92
AlogP:
3.68
PSA:
308.5
HBD:
12.0
HBA:
#RotB:
20.0
Source:
LOTAMILAST
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Phosphodiesterase 4 inhibitor
LOTAMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
TO043KKB9C
Molecule Type:
Small molecule
Molecular Formula:
C26H24N4O5
Molecular Weight:
472.5
AlogP:
4.39
PSA:
111.67
HBD:
2.0
HBA:
#RotB:
7.0
Source:
IFETROBAN
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Hepatorenal Syndrome; Respiratory Tract Diseases
Unknown
IFETROBAN
×
Maximum Phase:
2
First Approval:
None
UNII:
E833KT807K
Molecule Type:
Small molecule
Molecular Formula:
C25H32N2O5
Molecular Weight:
440.54
AlogP:
4.12
PSA:
101.66
HBD:
2.0
HBA:
#RotB:
11.0
Source:
AGANEPAG ISOPROPYL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AGANEPAG ISOPROPYL
×
Maximum Phase:
2
First Approval:
None
UNII:
R096XE6760
Molecule Type:
Small molecule
Molecular Formula:
C27H37NO4S
Molecular Weight:
471.66
AlogP:
6.45
PSA:
66.84
HBD:
1.0
HBA:
#RotB:
12.0
Source:
APLINDORE FUMARATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Dopamine D2 receptor partial agonist
APLINDORE FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
P13TV5A758
Molecule Type:
Small molecule
Molecular Formula:
C22H22N2O7
Molecular Weight:
426.43
AlogP:
2.11
PSA:
59.59
HBD:
2.0
HBA:
#RotB:
4.0
Source:
ST-101
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ST-101
×
Maximum Phase:
2
First Approval:
None
UNII:
7TTT61784C
Molecule Type:
Small molecule
Molecular Formula:
C15H12N2O
Molecular Weight:
236.27
AlogP:
1.85
PSA:
32.67
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AZD-9164
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Muscarinic acetylcholine receptor M3 antagonist
AZD-9164
×
Maximum Phase:
2
First Approval:
None
UNII:
977LWC4O5D
Molecule Type:
Small molecule
Molecular Formula:
C29H38FN2O2+
Molecular Weight:
465.63
AlogP:
4.92
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
7.0
Source:
SJG-136
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Neoplasms
DNA cross-linking agent
SJG-136
×
Maximum Phase:
2
First Approval:
None
UNII:
KT0ZQ64X1A
Molecule Type:
Small molecule
Molecular Formula:
C31H32N4O6
Molecular Weight:
556.62
AlogP:
4.52
PSA:
102.26
HBD:
0.0
HBA:
#RotB:
8.0
Source:
SNX 5422
2
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms; Leukemia; Lymphoma; Neoplasms
Heat shock protein HSP90 inhibitor
SNX 5422
×
Maximum Phase:
2
First Approval:
None
UNII:
BF52J69Q8T
Molecule Type:
Small molecule
Molecular Formula:
C25H30F3N5O4
Molecular Weight:
521.54
AlogP:
3.37
PSA:
142.33
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AZD7986
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD7986
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-690514
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
BMS-690514
×
Maximum Phase:
2
First Approval:
None
UNII:
VKU5X213Q7
Molecule Type:
Small molecule
Molecular Formula:
C19H24N6O2
Molecular Weight:
368.44
AlogP:
1.38
PSA:
100.94
HBD:
3.0
HBA:
#RotB:
5.0
Source:
OLVEREMBATINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bcr/Abl fusion protein inhibitor
OLVEREMBATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
KV1M7Q3CBP
Molecule Type:
Small molecule
Molecular Formula:
C29H27F3N6O
Molecular Weight:
532.57
AlogP:
4.68
PSA:
77.15
HBD:
2.0
HBA:
#RotB:
4.0
Source:
EDICOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Arthritis, Rheumatoid; Leukemia, Myeloid, Acute
Macrophage colony stimulating factor receptor inhibitor
EDICOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
3NU609VYNF
Molecule Type:
Small molecule
Molecular Formula:
C27H35N5O2
Molecular Weight:
461.61
AlogP:
5.97
PSA:
103.69
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SODIUM ACID PYROPHOSPHATE
2
Small molecule
Investigational
Unknown
Unknown
Pseudoxanthoma Elasticum
Unknown
SODIUM ACID PYROPHOSPHATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H5WVD9LZUD
Molecule Type:
Small molecule
Molecular Formula:
H2Na2O7P2
Molecular Weight:
221.94
AlogP:
-0.81
PSA:
124.29
HBD:
4.0
HBA:
#RotB:
2.0
Source:
CH-1504 L-ISOMER
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
CH-1504 L-ISOMER
×
Maximum Phase:
2
First Approval:
None
UNII:
86T288K8BS
Molecule Type:
Small molecule
Molecular Formula:
C23H23N5O5
Molecular Weight:
449.47
AlogP:
1.79
PSA:
181.52
HBD:
5.0
HBA:
#RotB:
9.0
Source:
1
2
…
96
97
98
99
100
101
102
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA